Join a Legacy of Innovation 110 Years and Counting!
Daiichi Sankyo Group is dedicated to the creation and supply of innovative pharmaceutical therapies to improve standards of care and address diversified, unmet medical needs of people globally by leveraging our world-class science and technology. With more than 100 years of scientific expertise and a presence in more than 20 countries, Daiichi Sankyo and its 16,000 employees around the world draw upon a rich legacy of innovation and a robust pipeline of promising new medicines to help people. Under the Group’s 2025 Vision to become a “Global Pharma Innovator with Competitive Advantage in Oncology,” Daiichi Sankyo is primarily focused on providing novel therapies in oncology, as well as other research areas centered around rare diseases and immune disorders.
Summary
The Senior Director, Global Oncology Medical Affairs is responsible for developing the Global Medical Affairs (GMA) strategy and tactical plan as part of the Global Brand Strategic Plan and leads the execution of the activities in the GMA plan including Launch Readiness and Life Cycle Management for the assigned compound and will report into the Global Oncology Medical Affairs Franchise Head.
Responsibilities
Responsible for the development of the Global Medical Affairs strategy and medical objectives for the assigned compound or therapeutic area and leads development, execution of the Global Medical Affairs plan and budget management including activities related to evidence generation, scientific engagement and communication as part of Launch Readiness activities and life cycle management from a medical perspective.
Serves as Global Medical Affairs Team (GMAT) Lead, to gain strategic and planning alignment across the matrix team consisting of regional medical affairs and core GMA functions. Represents medical affairs function as a member of the various cross-functional forums including, Publications Planning, Clinical and Safety sub-teams, Global Brand Team, and Global Product Team to inform
clinical development, commercialization, market access, and other cross-functional strategic discussions. Lead the team with sleeves rolled up, model the way and enable the team to act. Provides medical leadership to:
• Manage budgets and resources efficiently for GMA supported activities within the GMA plan, in collaboration with GMA Franchise Head
Qualifications: Successful candidates will be able to meet the qualifications below with or without a reasonable accommodation.
Education Qualifications (from an accredited college or university)
MD, PhD or PharmD required
Experience Qualifications
10 or more years Pharmaceutical industry experience or commensurate healthcare or research experience required
Minimum of 5 years of (in-house) medical affairs or related experience, global preferred
10 or more years Must have oncology experience, specifically in solid tumors required
10 or more years Previous overall responsibility and accountability for multiple indications of one or more compounds and related GMA plan/budget for related MA activities required
10 or more years Demonstrated ability to lead and influence others internally and externally required
10 or more years Experience leading matrix medical teams required
(e.g. GMAT) and representing medical on cross-functional leadership teams (e.g. Global Product Team, Global Brand Team, etc.) required
10 or more years Relationships with key external experts required
10 or more years Proven ability to manage multiple priorities at one time required
Knowledge of ADC or other biologics, or small molecules preferred
Demonstrated experience working with an alliance partner company preferred
Experience in hemato-oncology preferred
Travel
20-25% travel
Daiichi Sankyo, Inc. is an equal opportunity/affirmative action employer. Qualified applicants will receive consideration for employment without regard to sex, gender identity, sexual orientation, race, color, religion, national origin, disability, protected veteran status, age, or any other characteristic protected by law.